Article Details

Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection ... - Nature

Retrieved on: 2025-04-19 00:40:00

Tags for this article:

Click the tags to see associated articles and topics

Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection ... - Nature. View article details on hiswai:

Summary

The article discusses biotechnology's role in developing a protein-based vaccine against SARS-CoV-2, highlighting biotechnology's application in virology and zoonoses. It focuses on manipulating spike protein ectodomains to enhance immunogenicity against the virus.

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo